European Organisation for Research and Treatment of Cancer (EORTC) shared a post on LinkedIn:
“Have you seen the latest findings from the EORTC-BTG-1320 trial? This radiological post-hoc analysis explores how different tumour size measurements impact prognosis in recurrent WHO grade 2 and 3 meningiomas.
Key findings:
- Unidimensional and volumetric tumour progression are strongly associated with overall survival.
- Bidimensional tumour measurements are not significantly associated with overall survival.
- These insights could refine radiological monitoring and treatment planning in recurrent meningioma patients.
Discover how advanced imaging metrics could improve prognostic accuracy in neuro-oncology. Read more.”
More posts featuring European Organisation for Research and Treatment of Cancer.